Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
BiomX Inc has a consensus price target of $3.63 based on the ratings of 4 analysts. The high is $8 issued by Ladenburg Thalmann on May 12, 2022. The low is $2 issued by HC Wainwright & Co. on January 10, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on January 10, 2025, January 8, 2025, and August 16, 2024, respectively. With an average price target of $2 between HC Wainwright & Co., there's an implied 177.74% upside for BiomX Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for BiomX (AMEX:PHGE) was reported by HC Wainwright & Co. on January 10, 2025. The analyst firm set a price target for $2.00 expecting PHGE to rise to within 12 months (a possible 177.74% upside). 8 analyst firms have reported ratings in the last year.
The latest analyst rating for BiomX (AMEX:PHGE) was provided by HC Wainwright & Co., and BiomX reiterated their buy rating.
There is no last upgrade for BiomX
There is no last downgrade for BiomX.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BiomX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BiomX was filed on January 10, 2025 so you should expect the next rating to be made available sometime around January 10, 2026.
While ratings are subjective and will change, the latest BiomX (PHGE) rating was a reiterated with a price target of $2.00 to $2.00. The current price BiomX (PHGE) is trading at is $0.72, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.